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ABSTRACT 
Leukemia results from uncontrolled growth of genetically altered blood cells. Depending on 
the cell type of origin, the leukemia is defined as T-cell, B-cell, or myeloid and as acute or 
chronic depending on its characteristics.  
However, patients with a certain subtype of leukemia (e.g. acute myeloid leukemia (AML) or 
acute T-cell leukemia (T-ALL)) still exhibit great heterogeneity in response to treatment and 
clinical outcome. For optimal survival it is therefore necessary to identify high-risk patients 
who benefit from more intense treatment and stem cell transplantation as well as patients 
with lower risk that benefit from less intense treatment. The treatment response is influenced 
by the genetic alterations that drive the leukemia and mutation status may therefore be used 
as a prognostic marker for risk stratification. In Paper I and II we focused on genetic markers 
previously identified as relevant for risk stratification of adult patients with the aim to 
evaluate them in pediatric patients with acute leukemia. Our results identified presence of 
FLT3-ITD and high BAALC expression as independent markers for adverse prognosis in 
pediatric AML. In addition, we found that high ERG expression was predictive for an adverse 
prognosis in pediatric AML with MLL-rearrangement. We also identified that high expression 
of the NOTCH1 target gene HES1 was associated with better survival rates in children with 
T-ALL. This indicates that the level of NOTCH1-activity is predictive for prognosis in 
pediatric T-ALL. 
Paper III focuses on mechanisms of KRAS-induced myeloproliferative neoplasm (MPN) and 
T-ALL in mice. The mechanistic role of hyperactive RAS is well understood in myeloid 
malignancies while its role in T-cell leukemogenesis is less clear. We used LSL-
Kras2G12D;Mx1-Cre mice that models both MPN and T-ALL induced by hyperactive RAS 
and found that expression of KRASG12D had differential effects on the myeloid and T-
lymphoid lineages. While increased proliferation of myeloid cells induced MPN by expansion 
of mature myeloid cells, increased proliferation and partial block in T-cell differentiation led 
to an expansion of early T-cell progenitors. With time, secondary genetic events resulted in 
T-ALL transformation and we identified loss of heterozygosity at the Kras2 locus as a 
cooperating genetic event in T-ALL induced by KRASG12D. 
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